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ABSTRACT
RNA binding proteins (RBPs) are the primary gene
regulators in kinetoplastids as transcriptional con-
trol is nearly absent, making Leishmania an excep-
tional model for investigating methylation of non-
histone substrates. Arginine methylation is an evo-
lutionarily conserved protein modification catalyzed
by Protein aRginine Methyl Transferases (PRMTs).
The chromatin modifier PRMT7 is the only Type III
PRMT found in higher eukaryotes and a restricted
number of unicellular eukaryotes. In Leishmania ma-
jor, PRMT7 is a cytoplasmic protein implicit in patho-
genesis with unknown substrates. Using compara-
tive methyl-SILAC proteomics for the first time in
protozoa, we identified 40 putative targets, includ-
ing 17 RBPs hypomethylated upon PRMT7 knock-
out. PRMT7 can modify Alba3 and RBP16 trans-
regulators (mammalian RPP25 and YBX2 homologs,
respectively) as direct substrates in vitro. The ab-
sence of PRMT7 levels in vivo selectively reduces
Alba3 mRNA-binding capacity to specific target tran-
scripts and can impact the relative stability of RBP16
in the cytoplasm. RNA immunoprecipitation analy-
ses demonstrate PRMT7-dependent methylation pro-
motes Alba3 association with select target tran-
scripts and thus indirectly stabilizes mRNA of a
known virulence factor, -amastin surface antigen.
These results highlight a novel role for PRMT7-
mediated arginine methylation of RBP substrates,
suggesting a regulatory pathway controlling gene
expression and virulence in Leishmania. This work
introduces Leishmania PRMTs as epigenetic regula-
tors of mRNA metabolism with mechanistic insight
into the functional manipulation of RBPs by methy-
lation.
INTRODUCTION
Protein arginine methyltransferases (PRMTs) are widely
distributed across eukaryotes in nine different classes of
enzymes (PRMT1–9) (1). They catalyze arginine methyla-
tion in multiple cellular processes including histone modi-
ication, transcriptional control, RNA processing, protein
localization and cell signaling (1–3). Histones and RNA-
binding proteins (RBPs) have been characterized as PRMT
substrates in multiple organisms (1,4).
PRMTs are classiied as Type I, II or III according to
the targeted nitrogen and number of methyl groups trans-
ferred (1) (Figure 1B). PRMT7 is a unique enzyme as it
is the sole PRMT known to catalyze only monomethyl
arginine (MMA; Type III PRMT), which may indicate a
regulatory step that primes substrates prior to dimethy-
lation (1,5). PRMT7 has been well described in mam-
malian cells as a histone methyl-transferase which modu-
lates chromatin to repress gene promoters (6). Remarkably,
the only unicellular eukaryotes known to carry a PRMT7
homolog are choanolagellates and kinetoplastids, includ-
ing Leishmania, where gene expression control is primarily
post-transcriptional (4,7). The heightened regulatory role of
RBPs in Leishmania can lend clear functional insight not
obscured by complex networks of transcriptional regulation
(8).
Leishmania spp. parasites are the causative agent of the
leishmaniases, infectious diseases that contribute the ninth
largest global disease burden, with 1 million new cases di-
agnosed annually (9). We have previously shown that Leish-
mania major PRMT7 expression regulates host pathology,
is stage-regulated during development and is cytoplasmic-
*To whom correspondence should be addressed. Email: pegine.walrad@york.ac.uk
Present address: Tiago R. Ferreira, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
C© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which
permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
D
o
w
n
lo
a
d
e
d
 fro
m
 h
ttp
s
://a
c
a
d
e
m
ic
.o
u
p
.c
o
m
/n
a
r/a
d
v
a
n
c
e
-a
rtic
le
-a
b
s
tra
c
t/d
o
i/1
0
.1
0
9
3
/n
a
r/g
k
a
a
2
1
1
/5
8
2
8
9
1
8
 b
y
 g
u
e
s
t o
n
 0
5
 M
a
y
 2
0
2
0
2 Nucleic Acids Research, 2020
Figure 1. Heavy methyl SILAC is a feasible approach in Leishmania major promastigotes and does not signiicantly affect promastigote culture growth. (A)
L. majorwild-type (WT) and PRMT7 knockout (prmt7) parasites were kept in SILACmedia in the presence of light or heavy methionine (L-methionine-
methyl-13C,d3) with label-swap replications. Tryptic peptides were submitted to anti-monomethyl arginine (20) immunoprecipitation and LC–MS/MS for
identiication and quantiication of methyl peptides. (B) PRMT7 is the single Type III methyltransferase identiied to date and thus catalyzes only MMA.
Type II and Type I PRMTs catalyze, respectively, symmetric dimethylarginine (sDMA) and asymmetric dimethylarginine, in addition to MMA in a irst
step. (C) Expression of PRMT7 in logarithmic growth phase promastigotes was evaluated by immunoblotting for comparison between light and heavy
SILACmedia, which showed no signiicant difference. EF1a levels are shown for protein loading control. Blots are representative of a biological duplicate.
(D) WT and prmt7 promastigotes growth curves were not signiicantly altered in different SILAC media (light or heavy RPMI). If methionine is not
added to the culture media (noMet) parasite growth is not signiicant, which conirms the successful removal of methionine from the dialyzed fetal bovine
serum. Data are plotted as mean ± standard error from three biological replicates. (E) MS spectra of a representative WT-derived peptide showing 96%
incorporation of heavy methionine.
speciic in contrast to the primarily-cytoplasmic, partially
nuclear mammalian PRMT7 (5,10,11). Remarkably, the
Leishmania PRMT7-directed regulatory pathway epigenet-
ically controls parasite gene expression, and impacts host
pathology four differentiation events and months after
PRMT7 protein expression (10,12).
The impact of PRMT7 on the overall MMA-modiied
proteome is still unknown. To date, histones are the only
mammalian PRMT7 targets validated in vivo (1,6,13). In
contrast, L. major PRMT7 displays distinct localization,
low sequence similarity and is nonessential. Combined with
the negligible transcriptional control in Leishmania spp.,
all evidence suggests a divergent function between hu-
man and Leishmania PRMT7 enzyme (10). A recent large-
scale study compared the distribution of arginine residues
across eukaryotes and found that unicellular organisms that
carry a PRMT7 homolog (including Monosiga brevicolis
and Leishmania infantum) have a higher ratio of predicted
methylarginine/unmodiied arginine than others (Plasmod-
ium falciparum and Dictyostelium discoideum) (14). In-
deed both L. major and Trypanosoma brucei PRMT7s
are distinct enough from mammalian orthologs that the
regulatory pathways they drive may present anti-parasitic
drug targets or an opportunity to repurpose existing drugs
(2,4,10). We previously linked PRMT7 levels to L. major
parasite virulence and leishmaniasis pathogenesis (10).
Here, we present the irst comprehensive investigation
of the molecular impact of modulating PRMT7 levels and
the irst quantiied identiication of a Leishmania arginine
monomethyl proteome. Using methyl-SILAC proteomics,
we identiied 247 arginine monomethylated proteins, in-
cluding 62 RNA-binding proteins (RBPs); 17 of which are
hypomethylated upon PRMT7 knockout. RBPs are the pri-
mary genetic regulators in Leishmania species as genes are
constitutively transcribed (8). We further validate PRMT7
methylation targets both in vitro and in vivo and reveal argi-
nine methylation as an important post-translational regu-
lator of RBP function with differential impact upon indi-
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vidual trans-regulators. PRMT7-dependent monomethyla-
tion promotes cytoplasmic RBP16 protein stability as well
as controls the highly selective mRNA binding capacity of
Alba3; stabilizing δ-amastin surface antigen mRNA levels
but not impacting association or stability of nmt transcript
target. The near-absence of transcriptional control inLeish-
mania ampliies the regulatory role of trans-regulators and
renders it an excellent system to investigate the impact of
PTMs on RBP function (7). This study introduces Leish-
maniaPRMTs as epigenetic regulators of downstreampara-
site virulence viamodiiedRBP protein expression, selective
RNAbinding capacity and subsequentmRNAmetabolism.
MATERIALS AND METHODS
Leishmania major cultures and transfection
Leishmania major promastigotes strain CC1
(MHOM/IR/83/LT252) were cultured at 26◦C in M199
medium supplemented with 40 mM HEPES, 10% FBS,
100 U penicillin/ml, 100 g/ml, 100 M adenine, 0.0005%
Hemin. In the phlebotomine vector, L. major parasites
differentiate from the proliferative non-infective procyclic
promastigotes to the non-dividing human-infective meta-
cyclic promastigotes, a metacyclogenesis process that
is mimicked in culture (15). Procyclics and metacyclics
are enriched in axenic culture, respectively, at log and
stationary growth phases. Inside mammalian phagocytic
cells (primarily macrophages) metacyclic promastigotes
differentiate into non-motile amastigotes.
PRMT7 knockout parasites (prmt7) were previously
generated as described (10). Plasmid and PCR oligos
used in this study are shown in Supplementary Fig-
ure S2 and Supplementary Table S3, respectively. The
coding sequence (CDS) and 500 bp 5′ lanking region
(FLR) of RNA-binding proteins Torus (LmjF.36.0740),
DDX3 (LmjF.32.0400), RBP16 (LmjF.28.0825) and Alba3
(LmjF.34.2580) were PCR ampliied. The cloning strat-
egy involved using four different SiI enzyme sites to al-
low a single-step four-way ligation: SiA (GGCCACCTAG
GCC), SiB reverse (GGCCACGCAGGCC), SiC (GGCC
GCTGGGGCC) and SiD reverse (GGCCTGACTGGC
C) (16). PCR products were puriied using NucleoSpin
Gel and PCR Clean-up (Macherey-Nagel), cloned into
pGEM®Teasy vector (Promega), SiI digested and lig-
ated into plasmid pFLAG HA-RBP (Supplementary Fig-
ure S2A). Positive clones were conirmed by diagnostic
restriction and sequencing, PmeI–PacI digested overnight
and puriied DNA was transfected into L. major WT and
prmt7 using Amaxa Nucleofector IIb (Lonza). Transfec-
tants were selected on 1% agar M199 plates with 10 g/ml
G418 and PCR-validated using 5′FLR and 3′FLR primers
(Supplementary Figure S2B and C).
Alba3 hypomethylatedmutantswere generated by replac-
ing arginine residues (RG/RGG motifs) in the C-terminus
to either tryptophan (WGG) or lysine (R192K or KGG)
and inserting each construct into pFLAG HA-Alba3. For
the latter, alba3 sequence was modiied by Q5® Site-
Directed Mutagenesis (New England Biolabs) using oli-
gos shown in Supplementary Table S3 to either replace a
single arginine detected in the MMA methyl-SILAC anal-
ysis (Alba3R192K) or all the eleven arginine residues in
RGG motifs present in its C-terminal tail (Alba3KGG). The
Alba3WGG mutant sequence was obtained as a custom syn-
thetic gene (GenScript), in which each of the eleven arginine
residues were mutated. Final constructs were transfected
into both WT and prmt7 L. major cell lines.
Parasite labeling by SILAC
Heavy methyl-SILAC has been shown to provide high con-
idence methyl peptide matches, and it is considered the op-
timal method for identifying protein methylation in large-
scale proteomics (17). Parasites were cultured for 10 pas-
sages in SILAC-RPMI media (RPMI lacking Methion-
ine (Dundee Cell Products), 10% 3.5 kDa-dialyzed serum,
20 mM HEPES pH 7.4, 100 M adenine, 20 mM L-
glutamine, 100 U/ml penicillin, 100 g/ml streptomycin,
1 M biopterin, 0.0005% hemin) supplemented with ei-
ther L-methionine or L-methionine-methyl-13CD3 (Sigma-
Aldrich), for 10 passages corresponding to approximately
100 parasite divisions. L-Methionine is converted into S-
adenosylmethionine (18), the main biological methyl donor
for transmethylation reactions, which allows direct label-
ing of methylated substrates (3). Next, J774.2 macrophages
kept in SILAC-RPMI media for 4 passages were infected
with late-stationary phase promastigotes at a 10:1 ratio
to obtain recently differentiated promastigotes, as pro-
longed axenic promastigote culturing can alter virulence-
related features (19). Three hours post-infection, plates were
washed in incomplete RPMI and kept for 48 h under the
same conditions. Amastigotes were puriied and differenti-
ated into procyclic promastigotes in SILAC-RPMI at 26◦C
and cultured for three passages.
Parasite protein extraction and enrichment of monomethy-
lated arginine peptides
Procyclic promastigote (109 parasites) were pelleted at 2000
g for 10 min, washed in PBS and lysed (20 mM HEPES
pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM
sodium pyrophosphate, 1 mM -glycerophosphate) via
three rounds of sonication at 15 W for 15 s at room temper-
ature (RT) to avoid urea precipitation with 1 min intervals
on ice. Lysates were cleared at 20 000 g, 20 min, 15◦C and
supernatants were collected.
Sample preparation and enrichment of monomethyl argi-
nine peptides (20) were conducted using PTMScan[mme-
RG] kit (Cell Signaling Technology) according to manufac-
turer’s protocols with the following modiications; proteins
were reduced in 4.5 MDTT at 55◦C for 30 min, cooled on
ice and alkylated in 2 mg/ml iodoacetamide at RT for 15
min. Lysates were diluted 3-fold in 20 mM HEPES pH 8.0
and digested overnight in 10 g/ml trypsin-TPCK (Sigma-
Aldrich) and 10 MHCl, at RT under agitation. Digestion
was conirmed by SDS-PAGE and Coomassie Blue R stain-
ing. Digests were acidiied with triluoroacetic acid (21) to
a inal concentration of 0.1% and a pH strip was used to
conirm pH <3. Precipitate was formed at RT for 15 min.
Peptides were puriied using a Sep-Pak C18 column (Wa-
ters) connected to a 10 cc reservoir, pre-wet in 5 ml 100%
acetonitrile and washed sequentially in 1, 3 and 6 ml 0.1%
TFA. Acidiied peptide solution was cleared at 1800 g for
D
o
w
n
lo
a
d
e
d
 fro
m
 h
ttp
s
://a
c
a
d
e
m
ic
.o
u
p
.c
o
m
/n
a
r/a
d
v
a
n
c
e
-a
rtic
le
-a
b
s
tra
c
t/d
o
i/1
0
.1
0
9
3
/n
a
r/g
k
a
a
2
1
1
/5
8
2
8
9
1
8
 b
y
 g
u
e
s
t o
n
 0
5
 M
a
y
 2
0
2
0
4 Nucleic Acids Research, 2020
15 min at RT and cleared supernatant was loaded onto the
C18 column using a 10 cc plunger. The column was washed
sequentially in 1, 5 and 6 ml 0.1% TFA and then in 2 ml
5% acetonitrile, 0.1% TFA. Peptides were collected by three
elutions in 2 ml 40% acetronitrile, 0.1% TFA and dried in a
Speed-Vac concentrator for ∼3 h.
Dry peptide pellets were dissolved in 1.4 ml Im-
munoafinity Puriication (IAP) buffer (CST) and pH ∼7.0
was conirmed on a pH strip. All subsequent steps were per-
formed on ice or at 4◦C. Peptide solution was cleared at
10 000 g for 5 min and supernatant was transferred to a
fresh tube. Anti-MMA agarose beads from the PTMScan
kit (CST) were washed four times at 2000 g for 1 min, in
1 ml PBS (8 mM Na2HPO4; 1.5 mM NaH2PO4; 2.7 mM
KCl; 137 mMNaCl; pH 7.0) and resuspended in 40 l PBS.
Peptide solution was mixed with the anti-MMA beads and
incubated for 2 h under rotation. Peptide-beads slurry was
centrifuged at 2000 g for 1 min and unbound peptides were
collected and kept at –80◦C. Beads were washed twice in 1
ml IAP buffer and three times in HPLC-grade water; invert-
ing the tube ive times and centrifuged at 2000 g for 1 min.
MMA peptides were collected by two elutions in 55 l of
0.15% TFA at RT for 10 min, mixing every 2 min, and cen-
trifuged at 2000 g for 1 min.
Eluted monomethyl peptides were concentrated and pu-
riied using a Ziptip (Merck-Millipore). The Ziptip was irst
equilibrated in 50 l of 50% acetronitrile, 0.1% TFA and
twice in 50 l of 0.1% TFA. IP eluent was loaded by pass-
ing through the Ziptip 10 times. Tips were washed twice in
0.1% TFA and peptides were eluted in 10 l 40% acetoni-
trile, 0.1% TFA at least 10 times. Ziptip eluent was precipi-
tated in a Speed-Vac and MMA peptides were resuspended
in 10 l of 0.1% TFA.
Mass spectrometry data acquisition and analysis
Samples were loaded onto an UltiMate 3000 RSLCnano
HPLC system (Thermo) equipped with a PepMap 100 A˚
C18, 5 m trap column (300 m × 5 mm, Thermo) and a
PepMap, 2 m, 100 A˚, C18 EasyNano nanocapillary col-
umn (75 m × 150 mm, Thermo). The trap wash solvent
was 0.05% (v:v) aqueous triluoroacetic acid and the trap-
ping low rate was 15l/min. The trapwaswashed for 3min
before switching low to the capillary column. Separation
used gradient elution of two solvents: solvent A, aqueous
1% (v:v) formic acid; solvent B, aqueous 80% (v:v) acetoni-
trile containing 1% (v:v) formic acid. The low rate for the
capillary column was 300 nl/min and the column temper-
ature was 40◦C. The linear multi-step gradient proile was:
3–10% B over 8 min, 10–35% B over 125 min, 35–65% B
over 50 min, 65–99% B over 7 min and then proceeded to
wash with 99% solvent B for 4 min. The column was re-
turned to initial conditions and re-equilibrated for 15 min
before subsequent injections.
The nanoLC system was interfaced with an Orbitrap
Fusion hybrid mass spectrometer (Thermo) with an Easy-
Nano ionization source (Thermo). Positive ESI-MS and
MS2 spectrawere acquired usingXcalibur software (version
4.0, Thermo). Instrument source settings were: ion spray
voltage, 1900 V; sweep gas, 0 Arb; ion transfer tube tem-
perature; 275◦C.MS1 spectra were acquired in the Orbitrap
with: 120 000 resolution, scan range: m/z 375–1500; AGC
target, 4e5; max ill time, 100 ms. Data dependent acquisi-
tion was performed in top speed mode using a 1 s cycle, se-
lecting the most intense precursors with charge states 2–5.
Dynamic exclusion was performed for 50 s post precursor
selection and a minimum threshold for fragmentation was
set at 3e4. MS2 spectra were acquired in the linear ion trap
with: scan rate, rapid; quadrupole isolation, 1.6m/z; activa-
tion type, HCD; activation energy: 32%; AGC target, 5e3;
irst mass, 110m/z; max ill time, 100 ms. Acquisitions were
arranged by Xcalibur to inject ions for all available paral-
lelizable time.
Peptide identiication
Protein identiication was performed using Sequest HT
and Mascot. Thermo .raw iles were submitted to Se-
quest HT database searching using Proteome Discoverer
(version 2.1, Thermo). Peak lists were extracted follow-
ing .raw to .mgf format conversion using MSconvert (ver-
sion 3.0.9967, ProteoWizard) before submitting via Mas-
cot Daemon (version 2.5.1, Matrix Science Ltd) to a local-
running copy of theMascot program (version 2.5.1, Matrix
Science Ltd). Database searching was performed against
the TriTrypDB (version 8.1) (18) L. major Friedlin genome
(8400 sequences). Search criteria speciied: Enzyme, trypsin;
Fixed modiications, carbamidomethyl (C); variable modi-
ications, oxidation (M), phospho (ST), methyl (R), methyl
(K), methyl: 2H(7)13C(1) (R), Label: 13C(1)2H(7) (M),
Label: 13C(1)2H(7) + oxidation (M); peptide tolerance, 5
ppm; MS/MS tolerance, 0.5 Da; maximum missed cleav-
ages, 3; instrument, ESI-TRAP. Scaffold PTM (version
3.0.0, Proteome Software) was used to calculate methyla-
tion site localization probabilities for Mascot derived pep-
tide identiications using the algorithm as described (22).
Briely, MS2 spectra identiied as originating from methy-
lated peptides were re-analyzed to calculate Ascore values
and site localization probabilities to assess the level of con-
idence in each PTM positional assignment. Scaffold PTM
then combined localization probabilities for all peptides
containing each identiied PTM site to obtain the best es-
timate probability that a PTM is present at that particular
site.
Relative quantiication of methylated peptides
A list of unique, methylated peptides was compiled from
Sequest and Mascot identiications across all samples post-
iltering to require posterior error probabilities <0.05. The
list was used to calculate theoreticalm/z values for the light
and heavy analogues of all identiied methylated peptides.
Observed retention times from search results were associ-
ated with theoretical m/z pairs and appended to the mass
list to create an extracted ion chromatogram (XIC) tar-
get list. Where methylated peptides were identiied multi-
ple times the median retention time was used. Thermo .raw
iles were converted to .mzML using Bioconductor (ver-
sion 3.5) in R (version 3.3.1) before processing using the
xcms package (23). XICs were extracted for all theoreti-
cal light and heavy m/z pairs across retention time aligned
samples within 60 s windows, and peak areas extracted us-
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ing the centWave algorithm (24). Light and heavy peak ar-
eas were normalized to relative % (light/heavy) and the re-
ciprocal % (heavy/light) calculated for replicates originat-
ing from switched light to heavy metabolic labeling. Sig-
niicance testing for quantitative differences between nor-
malized light and heavy peak areas was performed using
Student’s t-test (two-tailed, heteroscedastic). Calculated P-
values were multiple-test corrected using the Hochberg and
Benjamini FDR estimation. Accepted differences were re-
quired to have corrected P-values <0.05, be derived from
XIC peak areas in>2 samples and be observed consistently
in at least one replicate upon light to heavy metabolic label
switching.
Bioinformatic analyses of PRMT7MMA RNA binding pro-
tein targets
Amino acid sequences of 18 PRMT7 RBP targets were
downloaded from TriTrypDB.org (18) and subjected to a
set of bioinformatic tools to predict the type and location
of constituent domains. Initial Pfam (25) domain annota-
tions were obtained using BLASTP (23) and RefSeq and
PDB sequence databases. Predictions of secondary struc-
ture and intrinsic disorder were performed using PSIPRED
(26) and DISOPRED (27), respectively. Additional struc-
tural predictions were conducted using Phyre2 in standard
mode (28). The results of these analyses were combined to
informmanual predictions of likely domain boundaries and
to annotate domain type and function. Extended regions of
predicted secondary structure and low disorder that lacked
a clear functional annotation were assigned as domains of
unknown function (DUF).
In vitro methylation assay by PRMT7
Recombinant proteins were expressed in Escherichia coli
BL21(DE3)pLys using pET28a+ (Novagen) and puriied
using Ni-Sepharose afinity medium (GE Healthcare).
Puriied and dialyzed proteins were analyzed on SDS-
PAGE and had their identity veriied by mass spectrom-
etry. PRMT7 wild-type and mutants were incubated with
putative substrates in PBS with 2 Ci of S-adenosyl-
[methyl-3H]methionine ([3H]AdoMet) (55–85 Ci/mmol,
PerkinElmer) for 18 h at 26◦C. Reactions were then halted
by the addition of 2× SDS sample buffer (125 mM Tris–Cl
pH 6.8, 20% glycerol, 2% SDS, 0.7 M -mercaptoethanol
and 0.01% bromophenol blue) at 95◦C for 5 min. Human
histone H4 was used as a positive control for PRMT7 ac-
tivity (1 g per reaction; New England Biolabs). Reactions
were loaded and run on 12.5% SDS-PAGE and gels were
dried on Whatman paper for 2 h at 80◦C on a gradient
drying cycle. The dried gel was exposed to Hyperilm (GE
Healthcare) for 3–14 days at –70◦C. Gels were also stained
with Coomassie R for loading control. Gels and ilms were
scanned on an ImageScanner III (GEHealthcare) for poste-
rior analysis using GIMP (GNU Image Manipulation Pro-
gram).
Immunoblotting
Mid-log or stationary promastigotes were pelleted at 2000
g for 10 min, washed in PBS, lysed in 2X SDS sample
buffer, boiled 5min and loaded (107 cells per lane) on 12.5%
SDS-PAGE gels. Proteins were transferred to PVDF mem-
branes at 20 V for 1 h using a Novex Semi-Dry blotter
(Thermo). Blots were blocked in 5% milk TBS-T (20 mM
Tris, 150 mM NaCl, pH 7.4, 0.05% Tween) for 1 h at RT,
or 5% BSA TBS-T for anti-PRMT7 blots. Primary anti-
bodies were diluted in 1% milk or BSA TBS-T: mouse anti-
HA [1:20 000] (Thermo); rabbit anti-MMA [1:3000] (Mul-
tiMab, CST); chicken anti-LmjPRMT7 [1:1000] (10), rab-
bit anti-TbRBP16 [1:1000] (29) andmouse anti-EF1a [1:200
000] (clone CBP-KK1, Merck-Millipore) for 18 h at 4◦C.
Blots were briely washed ive times in TBS-T and incubated
in secondary antibodies for 1 h. Membranes were washed
and incubated in ECL Prime (GEHealthcare) detection so-
lutions for 5 min prior to ECL Hyperilm exposure (GE
Healthcare).
Immunoluorescence
Procyclic ormetacyclic promastigote cells were incubated in
culture with 200 nM of MitoTracker™ Green FM (Molecu-
lar Probe) for 30 min at 26◦C, harvest and antibody stained
as described (30) using mouse anti-HA [1:500] (Sigma) or
rabbit anti-TbRBP16 [1:500] (29) and Alexa secondary an-
tibodies [1:10 000]. Images were acquired on a Zeiss LSM
710 confocal microscope and images were processed using
PerkinElmer Volocity software.
RNA immunoprecipitation and qRT-PCR
HA-Alba3 was immunoprecipitated from in vivo UV-
crosslinked log-phase promastigotes with anti-HA mag-
netic beads (Thermo) as described (8,30). Crosslinking
was performed with UVC using the LT40 ‘Minitron’ sys-
tem (UV03 Ltd) (21) for 120 s at 1.6 mJ/cm2, which
is less stressful to parasites and damaging to mRNA
(8). Total RNA was extracted from WT and prmt7 in-
put samples using Direct-zol RNA Miniprep (Zymo Re-
search). cDNA was synthesized from 2 g of total RNA
or 100–400 ng of RIP RNA using the SuperScript IV Re-
verse Transcriptase (Invitrogen). Absolute quantiication
curves were performed for each oligonucleotide pair us-
ing serial dilutions of cDNA. Relative quantiication (–
Ct) was performed using the Fast SYBR Green Mas-
ter Mix and Quantstudio 3 PCR System (Thermo Fisher)
as described (8). RNA levels were normalized to the 18S
rRNA and glycosomal glyceraldehyde 3-phosphate de-
hydrogenase (GAPDHg, LmjF.30.2980). GeneIDs of the
mRNAs are: NIMA-related kinase (LmjF.35.5190), nmt
(LmjF.32.0080), -amastin (LmjF.34.0500) and p1/s1 nucle-
ase (LmjF.30.1510). Primers are listed in SupplementaryTa-
ble S3.
Protein and mRNA decay
For protein stability evaluation, promastigotes at day 2
(log phase; non human-infective promastigote) or day
6 (stationary phase; human-infective promastigote) post-
inoculum were incubated in 200 g/ml cycloheximide at
26◦C and harvested at time-points up to 24 h for western
blotting as above. Membranes were stained post-transfer
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in Ponceau for loading controls. Densitometry analysis was
performed using ImageJ software (31).
For transcript stability analysis, log phase promastigotes
were incubated up to 4 h in 5 g/ml actinomycin D (Sigma)
to inhibit de novo transcription (32). Cells (2 × 107) were
harvested at speciic time points and lysed in Trizol reagent
(Invitrogen). Total RNA was extracted using Direct-zol
RNAMiniprep (Zymo Research). RNA levels were quanti-
ied by qRT-PCR as above, normalized to 18S rRNA. Pro-
tein and mRNA half-life was calculated using Prism soft-
ware (GraphPad) by a one-phase or two-phase decay ex-
ponential curve robust it (according to the observed decay
proile) with a Plateau constraint of 0.
RESULTS
RNA-binding proteins are the primary targets of arginine
monomethylation in L. major
To evaluate the impact of PRMT7 loss upon the arginine
monomethyl proteome of L. major, wild-type (WT) and
prmt7 parasites were labeledwith either L-methionine (33)
or L-methionine-methyl-13CD3 (heavy) and submitted for
methyl-SILAC proteomic analysis (Figure 1A). Expression
of PRMT7 was similar between light and heavy methyl-
labeled parasites (Figure 1C) and no signiicant growth dif-
ference was observed between WT and Δprmt7 cells, light
or heavy (Figure 1D). Heavy methionine incorporation of
>95% was conirmed by LC–MS (Figure 1E), which is suf-
icient and essential for SILAC analyses (34).
Comprehensive peptide quantiication by methyl-SILAC
revealed 40 proteins hypomethylated in prmt7 cells
(WT/prmt7 methyl peptide ratio >1.5) from the 247
MMA-containing proteins identiied (≥2 peptides and de-
tection in label-swap repetition; Figure 2A and B; Supple-
mentary Table S1). In total, these proteins are represented
by 387 unique MMA peptides identiied. Mass spectrome-
try analysis of unfractionated peptides (input) did not show
signiicant differential expression of total methylated pro-
teins between wild-type and Δprmt7 samples.
Molecular Function Gene Ontology (GO) Term analysis
reveals that nucleic acid binding and RNA-binding func-
tions are signiicantly enriched in the global MMA pro-
teome and more prominently in the Δprmt7 hypomethy-
lated proteins (Figure 2C and D). Among 62 RNA-binding
proteins (Supplementary Table S2), we found 24 differ-
entially methylated in Δprmt7 cells, of which 17 are hy-
pomethylated and represent putative substrates of PRMT7
activity (Supplementary Table S2). Analysis of the pep-
tide sequences surrounding the methylated arginines using
WebLogo 3 (35) demonstrates differential residue selection
between the hypomethylated arginines versus total MMA
proteome in Δprmt7 cells. The global MMA data do not
present a signiicant motif consensus, with 10–20% prob-
ability for glycines to surround the methylarginine (Fig-
ure 2C). However, there is a strong selection evident for
RG/RGG (or GR/GGR) motifs in the hypomethylated
PRMT7 substrate peptides (Figure 2D), revealing a can-
didate target motif for the PRMT7 enzyme. Of interest,
MMA sites in isolated hypomethylated RBPs reside outside
conserved Interpro/Pfam domains (Figure 3), suggesting
RBP–RNA interactions might not be directly obstructed.
Validating RBP substrates of PRMT7 methylation
From the list of proteins hypomethylated inprmt7, we se-
lected Alba3 (Alba20) (10,36,37) and RBP16 for further
investigation (Figure 2A). Alba3 is a RPP25-like protein
(ribonuclease P subunit p25-like) involved in the stabiliza-
tion of the -amastin virulence factor mRNA upregulated
in amastigotes (37). RBP16 is a Y-box binding protein
(YBX2-like) important for trypanosomatid mitochondrial
mRNA editing and stabilization (38). We previously identi-
ied these two RBPs as candidate targets of PRMT7methy-
lation (10). To determine whether these RBPs are direct tar-
gets of PRMT7 methylation, puriied recombinant 6xHis-
tagged PRMT7 (His-PRMT7) and putative substrates His-
Alba3 and His-RBP16 were tested for activity in vitro. We
irst conirmed His-PRMT7 activity is detectable in vitro
using a commercially available human Histone H4 (H4), a
canonical target of mammalian PRMTs (Figure 4A) versus
a protein containing 12 arginines but not an identiied tar-
get, prostaglandin f2-alpha synthase (PGF2S) (39). PGF2S
is not methylated by PRMT7 in vitro (Figure 4A–C).
Next, we examinedHis-PRMT7methylation of recombi-
nantHis-RBP16 andHis-Alba3, as well as amutant protein
devoid of the RGG-rich C-terminal tail (His-Alba3RGG,
Figure 4B). His-PRMT7 methylates His-AlbaWT and His-
RBP16WT in vitro in a concentration-dependentmanner but
not His-Alba3RGG (Figure 4C). This indicates that recom-
binant PRMT7 is suficient to monomethylate both RBP
targets directly and that PRMT7-catalyzed methylation re-
quires the C-terminal RGG motifs of Alba3, despite 18
additional non-RGG arginine residues still present in His-
Alba3RGG.
Building upon these observations, we generated two
catalytically-inactive PRMT7 mutants to conirm conser-
vation of the catalytic site in Leishmania and the speciicity
of the observed methylation signal (Figure 4B, D). In other
eukaryotes, key glutamate (E) residues in the double E loop
of the SAM-binding domain have been replaced to gener-
ate inactive PRMT mutants (40,41). Analysis of the dou-
ble E loop sequence of PRMTs in L. major showed conser-
vation of residues E202 and E211 (Supplementary Figure
S1). The irst glutamate residue in this domain (E202) was
mutated to either a glutamine or lysine accordingly (Fig-
ure 4B). In contrast to His-PRMT7WT, recombinant His-
PRMT7E202Q and His-PRMT7E202K do not methylate His-
Alba3 orHis-RBP16 in vitro (Figure 4D). These results con-
irm the catalytic domain and the double E loop are essen-
tial for PRMT7-dependent monomethylation of RBP tar-
gets in vitro.
Loss of PRMT7 impacts RBP expression and function in vivo
To investigate a possible role of MMA arginine in mRNA
metabolism in Leishmania parasites, the N-termini of se-
lect target RBPs were endogenously HA-tagged, leaving
3′UTRs intact as transcript stability and translational con-
trol are overwhelmingly 3′UTR-driven (8,42). Wild-type
and Δprmt7 parasites were engineered to express HA-
tagged Alba3, RBP16, Torus and DDX3 RBPs (Supple-
mentary Figure S2). Torus is a CCCH-type zinc inger
protein with a conserved Torus domain that, like DDX3
(HEL67) (43), co-immunoprecipitates with PRMT7 (10).
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Figure 2. RNA-binding proteins are putative substrates for PRMT7 arginine monomethylation. (A) Methyl-SILAC peptide pairs were analyzed according
to their methylation status in WT versus prmt7 Leishmania major cells. Mass spectra quantiication of each light and heavy pair ratios detected peptides
with increased (hypermethylated, in blue) or decreased (hypomethylated, in red) methylation in Δprmt7 as compared to WT. Methylated RNA-binding
proteins (RBPs) are shown as well as proteins that had nomethyl peptides detected inΔprmt7 (boxed RBPs). Of 247 identiied proteins with isolatedMMA
peptides, 62 are RBPs; 17 of which are hypomethylated in Δprmt7 (Hochberg and Benjamini test q < 0.05). (B) 51 proteins are differentially methylated
betweenWT andΔprmt7; 6 of which are both hypomethylated and hypermethylated at different residues. (C, D) Signiicantly enrichedMolecular Function
Gene Ontology (GO) Terms (upper panel) and selected amino acid residues (lower panel) in the wholeMMA proteome (C) versusΔprmt7 hypomethylated
proteins (D). For the global data, RNA binding was highlighted (upper panel), yet there is no clear consensus MMA site sequence (lower panel). RNA
binding remains characteristic ofprmt7 hypomethylated proteins, and an enrichment for the ‘RGG’ motif is evident (lower panel).Dotted lines in upper
panels depict Bonferroni P-value = 0.05.
Examination of HA-Torus, HA-RBP16 and HA-DDX3
levels in WT and Δprmt7 promastigote cells at log and
stationary stages show that these RBPs are differentially
expressed in the absence of PRMT7 levels (Figure 5A).
Both HA-Torus and HA-RBP16 have reduced expression
in Δprmt7 parasites, the former at both log and stationary
phase, the latter only in stationary promastigotes. In con-
trast, HA-DDX3 is slightly upregulated in Δprmt7 at sta-
tionary phase with potential degradative products evident.
The detection of a smaller HA-DDX3 band of ∼30 kDa at
the stationary phase suggests enzymatic cleavage, a possible
sign of protein instability and coordinated control of expres-
sion. The observation that these RBP protein levels are al-
tered in prmt7 relative to wildtype stationary phase cells
(Figure 5A) is interesting as PRMT7 expression is tightly
downregulated prior to this lifecycle stage (10). The stage-
speciic eradication of RBP16 levels in the prmt7 mutant
cells was therefore examined in two different but comple-
mentary experimental contexts.
To determine whether reduced HA-RBP16 levels in
Δprmt7 cells are due to expedited protein decay rates or
reduced translation of rbp16 transcript, the protein stabil-
ity of both RBP16 and Alba3 was assessed in WT versus
prmt7 cells (Figure 5B and Supplementary Figure S3). Of
note, the half-life of HA-RBP16 is reduced speciically in
stationary phase prmt7 cells relative to WT background
or log phase (Figure 5B). Densitometry analysis revealed
HA-RBP16 protein half-life is >6 h in WT and 0.86 h in
prmt7 cells at stationary phase (Figure 5B and Supple-
mentary Figure S3B). In contrast, stability of HA-Alba3
protein was unchanged between samples (Supplementary
Figure S3). This suggests PRMT7-dependent methylation
can post-translationally control select target protein degra-
dation rates in a stage-speciic manner.
To determine whether the half-life of HA-RBP16 was
impacted by subcellular localization, N-terminally tagged
HA-RBP16 was examined using immunoluorescence. Sim-
ilar to immunoblot results (Figure 5A, Supplementary Fig-
ure S4B), the HA-RBP16 protein signal speciically de-
creases in Δprmt7 promastigotes at stationary phase (Sup-
plementary Figure S4E). Unlike the close RBP16 ortho-
logue in T. brucei, TbRBP16 (38,44), N-terminally tagged
HA-RBP16 localises in the cytoplasm and does not appear
to trafic to the mitochondria (Supplementary Figures S4C
and E). Cytoplasmic localization of HA-Alba3 was unal-
tered between promastigotes samples (Supplementary Fig-
ure S4F). We therefore examined the subcellular localiza-
tion and relative stability of endogenous LmjRBP16 using
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Figure 3. Monomethyl arginines are found outside RNA-binding domains. Bioinformatic analysis of 18 PRMT7 targets showing sites where MMA was
detected and the predicted locations of different classes of RNA- or protein-binding domains. RNA-binding domains are colour coded (see legend) while
protein-binding domains are annotated and shown in gray. Regions lacking an identiiable domain or with predicted disorder are shown by a solid line.
Domain annotations: DUF, domain of unknown function;KH,K homology; LRR, Leucine-rich repeat; LSm, like Smith antigen; NFT2, nuclear transport
factor 2; SAM, sterile alpha motif; SBDS, Shwachman–Bodian–Diamond syndrome protein; YTH, YT521-B homology. Positions of domain boundaries
and methylated arginines are relative to the scale bar. Entries ordered by TriTrypDB gene identiier. Protein names provided where assigned.
anti-TbRBP16 (kind gift of L. Read), and found that while
the HA-RBP16 protein is cytoplasmic, untagged endoge-
nous LmjRBP16 is indeed mitochondrial (Supplementary
Figures S4C and D). We tested the subcellular localiza-
tion of C-terminally-tagged endogenous RBP16-HA and
found it is also mitochondrial (data not shown). This sug-
gests N-terminal HA tagging of LmjRBP16 is suficient to
disrupt proper mitochondrial localization. Of note, neither
the mitochondrial-localised endogenous LmjRBP16 or en-
dogenously tagged LmjRBP16-HA are destabilized in the
stationary cell stage in the absence of PRMT7 levels (Sup-
plementary Figure S4A). As the rbp16 transcript is nuclear-
derived and cytoplasmically translated, there is biological
relevance to the relative stability of this potential metabolic
regulator in the cytoplasm. This provides two useful mech-
anistic insights, irstly that PRMT7 methylation can shield
a cytoplasmic RBP from protein degradation in an in vivo
context and secondly that the protein degradation is distinct
between cytoplasmic and mitochondrial cellular compart-
ments and between lifecycle stages.
PRMT7-mediated methylation modulates post-
transcriptional gene control
Unexpectedly, endogenous levels and subcellular local-
ization of HA-Alba3 remain constant despite removal
of PRMT7 expression (Figure 6A, Supplementary Fig-
ure S4D). We generated hypomethylated Alba3WGG, HA-
Alba3KGG and HA-Alba3R192K heterozygous mutants with
RGG methyl sites replaced by WGG or KGG in the pro-
tein C-terminus to evaluate target speciicity. In contrast to
other RBPs investigated, there were no changes in either
endogenously tagged HA-Alba3WT, HA-Alba3WGG, HA-
Alba3KGG or HA-Alba3R192K protein levels in the absence
of PRMT7 levels (Figures 6A and 7A). Immunoprecipita-
tion of HA-Alba3 and probing with anti-MMA revealed
that monomethylation is only detected in WT cells and ab-
sent in all mutant HA-Alba proteins expressed in both WT
andprmt7 cell lines (Figures 6B and 7B), validating the C-
terminal RGG motifs, and isolating R192 as necessary for
in vivo Alba3 methylation by PRMT7. Therefore, we inves-
tigated the potential inluence of arginine methylation on
Alba3 mRNA-binding function.
Previously, LiAlba3 has been shown to bind to -
amastin (LinJ.34.1010) and p1/s1 nuclease (LinJ.30.1520)
transcripts in Leishmania infantum cells (36). Therefore,
we tested whether Alba3 RNA-binding is conserved and
impacted by PRMT7-dependent methylation. Promastig-
otes cells were UV-crosslinked in vivo followed by anti-
HA RNA immunoprecipitation (RIP) to isolate HA-Alba3
mRNP complexes and speciic transcript targets were quan-
tiied by qRT-PCR. Remarkably, endogenous HA-Alba3
showed differential RNA-binding afinity in the absence
of PRMT7-dependent methylation. The in vivo interac-
tion of Alba3 with stage-regulated mRNAs -amastin
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Figure 4. In vitro methylation of Alba3 and RBP16 by PRMT7. (A) Recombinant His-PRMT7 was tested for methyltransferase activity in vitro in the
presence of radioactive methyl donor S-adenosyl methionine, human histone H4 as (1 g) a canonical RGG-containing PRMT substrate (black arrow)
and a Leishmania braziliensis protein rich in arginines but devoid of RGG motifs as a negative control (LbrPGF2S). (B) Puriied His-tagged PRMT7
putative substrates Alba3WT, RBP16WT and RGG-deicient Alba3RGG were tested, as well as LbrPGF2SWT. PRMT7 E202 residue in the double E
loop motif was mutated to K or Q to generate catalytically-inactive mutants. (C) RNA-binding proteins Alba3WT and RBP16 are arginine methylated by
PRMT7 in vitro, while Alba3RGG and LbrPGF2SWT are not. (D) In vitro methylation of target RBPs by PRMT7 is disrupted by mutating residue E202
(PRMT7E202K and PRMT7E202Q). Coomassies demonstrate relative loading.
(LmjF.34.0500) and p1/s1 nuclease (LmjF.30.1510) is de-
pendent on methylation by PRMT7 (Figures 6C, D and
7C). In contrast, Alba3 binding to the constitutively-
expressed nmt (N-myristoyltransferase) and gapdh mRNA
targets is not altered by PRMT7 knockout. While total -
amastin expression levels are reduced in Δprmt7, nmt tran-
script levels are constant, suggesting divergent regulatory
mechanisms between the two transcripts (Figure 6D).
To further analyze Alba3 binding to -amastin, HA-
Alba3WT, HA-Alba3WGG, HA-Alba3R192K and HA-
Alba3KGG mRNPs were puriied from WT and prmt7
samples and quantiied by qRT-PCR. Interaction between
Alba3 and -amastin mRNA is consistently inhibited in
prmt7 cells in vivo (Figures 6C, D and 7C). This interac-
tion was disrupted in HA-Alba3WGG and HA-Alba3KGG
(Figures 6D and 7C), corroborating the role of C-terminal
tail methylation upon Alba3 RNA-binding capacity. As
a control, nmt mRNA associates with Alba3 at similar
levels in WT and prmt7 cells and nmt transcript stability
is unchanged (Figures 6C–E and 7C). Notably, while the
speciic mutation of arginine 192 to a lysine (R192K)
was suficient to ablate Alba3 MMA by PRMT7 in vivo,
this does not disrupt Alba3 association with -amastin
or nmt, but is suficient to disrupt association with p1s1
target transcript (Figure 7C). Indeed, the trypsin digest
of proteins prior to isolation of monomethylated peptides
may have disrupted the proper identiication of multiple
RGG motif-containing peptides from within the Alba3
C-terminus, and possibly other target proteins. This sug-
gests Alba3 association with -amastinmRNAmay require
PRMT7-dependent monomethylation of C-terminal RGG
motifs in addition to R192.
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Figure 5. PRMT7 knockout affects target RBP expression in vivo. (A) Expression levels of three endogenously-tagged RBPs, Torus, RBP16 andDDX3, are
altered in Δprmt7 (7) parasites. Lanes are labeled for logarithmic (log) versus stationary (stat) phase promastigotes. EF1a levels are shown as a loading
control. (B) HA-RBP16 protein stability was analyzed in log and stationary promastigotes after cycloheximide (CHX) addition. Ponceau staining is shown
as loading control. HA-RBP16/Ponceau ratio values are shown below each lane. HA-RBP16 protein half-life was >6 h in WT cells and 0.86 h in prmt7
according to a one-phase and a two-phase decay exponential it, respectively.
It has been reported that Alba3 participates in the stabi-
lization of -amastin mRNAs in L. infantum (36). We thus
investigated whether PRMT7-mediated methylation affects
-amastin transcript stability. Samples from cells treated
with actinomycin to block transcription, revealed that -
amastin is only stabilized when Alba3 is monomethylated
(Figures 6E and 7C). Either PRMT7 knockout or expres-
sion of hypomethylated Alba3 resulted in a signiicant de-
crease of -amastin mRNA half-life from 3.8 h in WT to
0.95 h in prmt7 (Figure 6E). Collectively, this indicates
PRMT7-dependent MMA methylation of Alba3 impacts
RNA binding in a target-speciic manner. In summary, our
data demonstrate methylation by PRMT7 can regulate the
relative protein stability and selective RNA afinity of dis-
tinct RBP targets.
DISCUSSION
To date, a limited number of arginine methylated pro-
teins have been identiied in Leishmania spp. (10,45). In
this study, we report that 3% (∼247) of the entire L. ma-
jor predicted proteome carries at least one monomethy-
lated arginine (20). This number of MMA-targeted pro-
teins is relatively large considering arginines can also be
dimethylated and since other post-translational modiica-
tions (PTMs) have been detected inLeishmania spp., includ-
ing ∼600 phosphorylated proteins (7%) (46). We demon-
strate that PRMT7-dependent methylation strongly im-
pacts the MMA proteome of L.major parasites thus regu-
lating RBP expression and/or function (Figure 8). Notably,
PRMT7 levels regulate the expression levels of three iso-
lated RBP targets in at least one developmental stage (Fig-
ure 5A), suggesting that argininemethylation can affect pro-
tein turnover in Leishmania spp.
Overall, experimental evidence indicates Leishmania ma-
jor PRMT7 activity impacts protein target stability (Figure
5) and function (Figures 6 and 7) in a context-dependent
manner, distinct from that of mammalian homologs. De-
spite not being an essential protein inL. major, PRMT7 lev-
els regulate leishmaniasis disease pathology (10). Remark-
ably, epigenetic control by PRMT7-dependentmonomethy-
lation of the primary gene regulators in this system, RBPs,
mediates virulence of the human-infective lifecycle stage
four differentiation events downstream of PRMT7 expres-
sion. This undermines the traditional paradigm that inlu-
ential trans-regulators are temporally synchronizedwith the
cellular processes they promote and provides another layer
of depth to the complexities of Leishmania genetics.
Interestingly, 17 proteins are hypermethylated inΔprmt7
parasites (Figure 2A and B). This and the viability of
Δprmt7 parasites may suggest modulation of alternative
PRMT activity to functionally compensate for PRMT7
depletion. Six of the hypermethylated proteins also con-
tain distal sites which are hypomethylated; indicative of a
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Figure 6. Arginine methylation of Alba3 contributes to mRNA binding and -amastin stabilization. (A) Endogenously tagged Alba3WT and RGG→WGG
hypomethylated mutant (Alba3WGG) showed no differential expression levels between WT and prmt7 cells. The migration of HA-Alba3WGG mutant
protein is faster on SDS-PAGE, independent of PRMT7 levels. (B) Immunoprecipitation of HA-Alba3 shows loss of arginine monomethylation inprmt7
parasites and when the C-terminal RGG motifs are mutated into WGG. (C) Alba3 complexes were puriied by RNA co-immunoprecipitation (RIP) from
in vivoUV-crosslinked cell lysates. Eluted RNA are analyzed by qRT-PCR and suggest that -amastin and p1/s1 nuclease, but not gapdhg or nmt transcript
binding to Alba3 decreases in the absence of PRMT7 levels. RIP transcript levels are relative to 18S rRNA in upper panel and lower panel are relative
to total cellular levels (input). *P < 0.05, Bonferroni two-way ANOVA test. (D) qRT-PCR analysis of -amastin (upper panels) and nmt (lower panels)
mRNA association to HA-Alba3 and HA-Alba3WGG mutant. Quantiication of HA-Alba3 RIP eluted transcripts (left panel) and total input RNA (right
panel) is shown. *P < 0.05, **P < 0.01, Tukey one-way ANOVA test (left panel) and unpaired two-tailed t-test (right panel). (E) Stability of -amastin
(left panel) and control nmt (right panel) transcripts were evaluated in wild-type (WT) and prmt7 after actinomycin treatment. RNA samples from cells
expressing wild-type (Alba3WT) or hypomethylated (Alba3WGG) Alba3 were used in qRT-PCR. -amastin mRNA half-life was >3.8 h in WT and 0.95 h
in prmt7 cells expressing HA-Alba3WT, and, respectively, 1 and 1.2 h for HA-Alba3WGG. Transcript levels were normalized against 18S rRNA and are
plotted as mean ± standard error of two biological replicates. **P < 0.01, Bonferroni two-way ANOVA test.
D
o
w
n
lo
a
d
e
d
 fro
m
 h
ttp
s
://a
c
a
d
e
m
ic
.o
u
p
.c
o
m
/n
a
r/a
d
v
a
n
c
e
-a
rtic
le
-a
b
s
tra
c
t/d
o
i/1
0
.1
0
9
3
/n
a
r/g
k
a
a
2
1
1
/5
8
2
8
9
1
8
 b
y
 g
u
e
s
t o
n
 0
5
 M
a
y
 2
0
2
0
12 Nucleic Acids Research, 2020
Figure 7. Arginine methylation of Alba3 contributes to binding of δ-amastin and p1s1 mRNAs. (A) Endogenously tagged Alba3WT, RGG→KGG sin-
gle point mutant (Alba3R192K) and hypomethylated mutant (Alba3KGG) showed no differential expression levels between WT and Δprmt7 cells. The
migration of HA-Alba3KGG mutant protein is faster on SDS-PAGE, independent of PRMT7 levels. (B) Immunoprecipitation of HA-Alba3 shows argi-
nine monomethylation is ablated in the RGG→KGG single point mutant (Alba3R192K), when all C-terminal RGG motifs are mutated into KGG (HA-
Alba3KGG) and in Δprmt7 parasites. (C) Alba3 complexes were puriied by RNA co-immunoprecipitation from in vivoUV-crosslinked cell lysates. Eluted
RNA were analyzed by qRT-PCR and conirm that Alba3 binding to δ-amastin and p1/s1 nuclease decreases in the absence of PRMT7, but Alba3:nmt
association remains constant independent of R mutation or PRMT7 levels. Interestingly, mutation of R192K disrupts Alba3:p1s1 association, but only
mildly impacts Alba3:δ-amastin binding. Transcript levels are relative to 18S rRNA. *P < 0.05, **P < 0.01, Bonferroni two-way ANOVA test.
complex PRMT inter-regulatory system. Deletion of mam-
malian PRMT1, which catalyzes asymmetric dimethylargi-
nine (43), results in an increase of global MMA in mam-
mals and T.brucei (47,48). Therefore, functional overlap be-
tween Leishmania PRMTs may involve a dynamic regula-
tory interplay as it does in T.brucei (49). A unique example
of substrate competition by PRMTs in human cells is reg-
ulation of transcription elongation factor E2F-1-mediated
apoptosis by arginine methylation (50). Here, PRMTs de-
termine apoptotic outcomes by competing for the same
E2F-1 substrate; SDMA methylation by PRMT5 leads to
apoptosis in DNA damaged cells, while ADMA methy-
lation by PRMT1 favors proliferation. The detection of
PRMT3MMApeptides in our isolates (LmjF.03.0600; Sup-
plementary Table S1) further supports methyltransferase
inter-regulation. While PRMT3 is catalytically inactive in
T. brucei due to the absence of key residues in the SAM-
binding domain (51), the two essential glutamate residues
in the double-E loop are still present inLeishmania (Supple-
mentary Figure S1), suggesting a different regulatory role
for LmjPRMT3. This exciting distinction suggests PRMT3
may be a functional enzyme rather than a prozyme inLeish-
mania.
Argininemethylation sites vary considerably according to
the PRMTenzyme or the organism investigated (2). RGand
RXR sites represent the majority of mammalian PRMT
target motifs but there are exceptions (41). Our methyl-
SILAC analysis identiied RG/RGG as the main target for
PRMT7 methylation in vivo. Conserved protein domain
analysis revealed that most of PRMT7-dependent methyla-
tion is not found directly within classical RNA-binding do-
mains (Figure 3). Of interest, despite the capacity to mod-
ify H4 in vitro (Figure 4A), no histone MMA peptides were
identiied by our screen (Figure 2A, Supplementary Table
S1). This could be due to the cytoplasmic-speciic localiza-
tion of LmjPRMT7, methodological limitations or a low
overall abundance ofMMA inLeishmania histone proteins.
Although arginine methylation has been mostly associ-
ated with changes in protein-protein interactions (2), there
aremultiple examples of direct modulation of RNA-protein
binding in mammalian cells (52–54). PRMTs have previ-
ously been shown to regulate the RNA afinity of target
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Figure 8. PRMT7 regulates RNA-binding protein function in Leishmania. Overview diagram describing the putative role of PRMT7-dependent methy-
lation based on the effects of L. major PRMT7 knockout upon the arginine methylation of selected RBPs. Red circles represent RBPs hypomethylated
in prmt7, while blue are hypermethylated. PRMT7 contributes to the protein stability of cytoplasmic RBP16 in stationary promastigotes and to Alba3
RNA-binding afinity to -amastin and p1/s1 nuclease mRNAs. Hypomethylation of Alba3 consequently results in decreased δ-amastin half-life.
RBPs in other systems (55,56). In T. brucei, the RNA-
binding proteins DRBD18 and PRMT1 have been shown
to modulate the fate of mRNAs according to methylation
state, impacting both protein and mRNA binding (51,57).
Here, we dissect the effect of MMA upon RNA afinity and
isolate the speciic arginines of Alba3 that are monomethy-
lated by PRMT7; resulting in the discrete maintenance or
loss of speciic transcript targets. In line with the previous
inding that L. infantum Alba3 stabilizes -amastin tran-
scripts (36), we ind that overall -amastin levels are sig-
niicantly reduced in the prmt7 mutant L. major lines.
This indirect regulation of -amastin by PRMT7 levels is
most likely due to reduced association with the hypomethy-
lated Alba3. Amastins are thought to function as mem-
brane transporters and are largely regarded as important
virulence factors in Leishmania species as reduced levels of
-amastins via gene knockdown limits pathogenesis of in-
fection in mice (58).
Our results indicate arginine monomethylation of the
Alba3 C-terminus increases binding to δ-amastin and pro-
motes transcript stabilization (Figures 6C-E and 7C). Un-
like -amastin, expression levels of p1/s1 nucleaseAlba3 tar-
get transcript are not altered by PRMT7 levels, although
arginine methylation of Alba3 R192 is necessary for as-
sociation (Figure 7C). In contrast, Alba3 transcript target
nmt is not impacted by PRMT7 levels (Figures 6C–E and
7C). These results suggest Alba3 regulates mRNA fate in
a highly bespoke and transcript-speciic manner. There is
a low correlation between protein expression and mRNA
binding capacity of RBPs and mRNPs display context-
dependent selection of components in Leishmania (8). Fur-
ther investigation of the molecular requirements and func-
tional impact of RBP modiication is therefore crucial to
understanding gene regulation not only in Leishmania, but
all eukaryotes.
The impact of PTM upon RNA binding potential may
be indirect. The CCCH zinc inger protein ZFP3 is known
to associate with ZFP1 in T.brucei and this interaction is
necessary for both RNA target speciicity as well as polyso-
mal association (59). Here, we identify ZFP3 as a target
of PRMT7-dependent MMA in Leishmania (Figure 2A).
It is possible a ZFP3:ZFP1 interaction could be impacted
by the presence of methylarginine altering both the RBP
spatial proximity and RNA target binding. In silico dock-
ing analyses suggest several residues in the Alba domain are
buried inside the Alba3:Alba1 heterodimeric protein com-
plex but the RGG motif in the C-terminal tail is exposed
(60). Consistent with the absence of RGGmotifs, the Alba1
protein was not detected in our methyl-SILAC analysis. It
is not known whether methylation of the Alba3 RGG tail
regulates the stress-induced localization of the Alba pro-
teins (37). Proper characterization of MMA target RBP
structural dynamics is necessary to determine the impact of
methylation on mRNP complex assembly.
Unusually, PRMT7-dependent methylation promotes
the stability of cytoplasmic RBP16 protein beyond the
temporal expression of PRMT7 protein levels (Figure 5
and Supplementary Figure S4). The regulation of protein
turnover observed represents a novel function for PRMT7-
dependent methylation (Figure 5). T. brucei RBP16 was
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the irst Y-box protein to be found in mitochondria, where
it associates with guide RNAs (gRNAs) and has a role
in mitochondrial mRNA editing (29,38). The N-terminal
cold-shock domain andRGG-rich C-terminus ofTbRBP16
both contribute to RNA-binding capacity (61). Arginine
residues in the T. brucei RBP16 C-terminus are targeted
by PRMT1methylation, impactingRNAediting complexes
(38). We ind that RBP16 in Leishmania is also mitochon-
drial and this localization is not affected by the absence
of PRMT7 (Supplementary Figure S4B). However, the N-
terminal tagging of endogenous RBP16 protein renders it
cytoplasmic, where the RBP half-life is speciically reduced
in prmt7 knockout cells in a human-infective stage (Fig-
ure 5, Supplementary Figure S4C). This reduced stability
suggests protein degradation can be inhibited in wild-type
cells via PRMT7-dependent methylation, which is partic-
ularly interesting at a lifecycle stage at which PRMT7 is
not expressed. This lends insight into the distinct cellular
microenvironments inluencing protein degradation in cy-
toplasm versus mitochondria to impact RBP function and
stability. Potential mechanisms include inhibition of protein
ubiquitination and proteasome degradation targeting. Cy-
toplasmic protein turnover rate is largely regulated by the
ubiquitin–proteasome system and polyubiquitination is the
classical marker for this pathway (62). Interdependent ubiq-
uitination and methylation has been detected previously in
other systems (63,64). In mammalian innate immune re-
sponse, TNF receptor-associated 6 (TRAF6) ubiquitin lig-
ase activity is inhibited by PRMT1 methylation (64). Ac-
tivation of Toll-like receptor response leads to hypomethy-
lated TRAF6 via demethylation by JMJD6 and downregu-
lation of PRMT1 expression. This triggers TRAF6 ubiqui-
tin ligase activity and NF-kB response. In L. major, a pu-
tative JMJD6 demethylase ortholog gene may enable dy-
namic arginine methylation in protozoa (Tritrypdb.org). To
fully understand the function of RBP16 in these parasites
we must examine other PTMs controlling RBP16 function.
The Lsm domain-containing SCD6 is another protein
with simultaneous identiication of hypo- and hypermethy-
lated sites (Figure 2A and Supplementary Table S1). This
RBP is involved in processing body (P-body) granule for-
mation inT. brucei; speciically responsible for coordinating
granule assembly (65). Sequential deletion of the TbSCD6
RGGmotifs, orthologous to targets of PRMT7methylation
identiied by our Leishmania screen, led to a proportional
decrease in RNA granule numbers in T. brucei. This sug-
gests arginine methylation may play a crucial role in con-
trolling the fate of all mRNPs in the cell; impacting both
mRNA metabolism and sequestration. At least four other
methylated RBPs have been shown to co-purify with RNA
granules in T. brucei: DDX3, PABP1, DRBD4 and Alba3
(66).
In conclusion, we introduce Leishmania as a model or-
ganism to speciically study PRMT activity and functional
impact of methylation upon non-histone targets. We ex-
plore methyl-SILAC as a productive, veriied approach
to investigate protozoa PRMT function and target isola-
tion. Our data indicate that PRMTs have a central role in
mRNAmetabolism control by modulating the stability and
function of post-transcriptional regulators in Leishmania.
PRMT7 activity thus has a demonstrated role in gene ex-
pression control, both directly at the post-translational level
and indirectly at the post-transcriptional level. Taken to-
gether, our data indicate the Leishmania PRMT7-directed
regulatory pathway epigenetically controls parasite gene ex-
pression long after PRMT7 expression.
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